Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2005
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP1059916B1 Extended release dosage form
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005CN1692127A TACI antibodies and uses thereof
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692102A Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
11/02/2005CN1691959A Interleukin 6 production inhibitor
11/02/2005CN1691953A Method for producing avocado leaves extract rich in furan lipids
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1225459C NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/02/2005CN1225268C 'Sanhuang' dripping pills and preparing method thereof
11/02/2005CN1225266C Medicine for treating wind rheumatism, injuries from falls and ulcer in opening of sore
11/02/2005CN1225263C Chinese herbal medicine for birds and beasts use and its preparing method
11/02/2005CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof
11/01/2005US6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005US6960674 A lipoxin compound for treating polymorphoneutrophil (PMN) inflammation
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960593 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones which control inflammatory cytokines
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960565 Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNS) in a tissue, its selection, pharmaceutical compositions and use
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
11/01/2005CA2115792C Method for the treatment of pain
10/2005
10/29/2005CA2501422A1 Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100562A1 OSTEOPONTIN siRNA
10/27/2005WO2005100558A1 Cd40 ligand mutant and utilization of the same
10/27/2005WO2005100365A1 Thienopyridine derivatives
10/27/2005WO2005100362A1 Liquid external preparation containing pranoprofen
10/27/2005WO2005100341A1 2-aminopyridine derivative
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099725A1 Preventive and/or remedy for inflammatory bowel diseases
10/27/2005WO2005099671A2 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239895 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/27/2005US20050239872 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
10/27/2005US20050239868 Indometacin preparation for external use
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239846 Use of vanilloid receptor antagonists for the treatment of pain
10/27/2005US20050239835 controlling weight gain; 1-(1-amino-2-phenylethylcarbonyl)-4-cyclohexylpiperidine compounds
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239824 Triple monoamine reuptake inhibitors for the treatment of chronic pain
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239781 For therapy of inflammatory disease and cancer
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239754 S-[2-[(1-Iminoethyl)amino]ethyl]-2-methyl-L-cysteine salicylate monohydrate crystalline salt
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050238670 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections
10/27/2005US20050238643 Modulation of lir function to treat rheumatoid arthritis
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005DE102004016683A1 Dauerhaft geschäumte Zusammensetzung Permanently foamed composition
10/27/2005CA2563689A1 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/27/2005CA2562827A1 Thienopyridine derivatives
10/27/2005CA2562602A1 2-aminopyridine derivative
10/27/2005CA2562473A1 Preventive and/or therapeutic agent for inflammatory bowel diseases
10/27/2005CA2562369A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005CA2562193A1 Treatment of neuropathic pain with zinc finger proteins
10/27/2005CA2561564A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1588727A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588692A1 Durable foamed composition
10/26/2005EP1587521A1 Bioavailability enhancing activity of carum carvi extracts and fractions thereof
10/26/2005EP1587516A1 Amide and ester matrix metalloproteinase inhibitors
10/26/2005EP1587482A2 Anti-inflammatory compositions and uses thereof
10/26/2005EP1328236A4 Methods of decreasing or preventing pain using spicamycin derivatives
10/26/2005EP1299406B1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
10/26/2005EP1073415B1 Pharmaceutical compositions capable of being gelled
10/26/2005CN1688604A Recombinant anti-osteopontin antibody and use thereof
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688582A Fused azole-pyrimidine derivatives
10/26/2005CN1688580A Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688577A Triazaspiro [5.5] undecane derivatives and drugs comprising the same as the active ingredient
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688554A 1, 2, 4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/26/2005CN1688553A Chemical process
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1688365A Therapeutic use
10/26/2005CN1688303A Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
10/26/2005CN1688290A Cannabinoid liquid formulations for mucosal amdinistration
10/26/2005CN1224707C Intracellular isoform of the interleukin-1 receptor antagonist
1 ... 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 ... 1272